Marco Foppoli

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 662 citations · Full text

Medicine, Oncology, Pharmacology +10

Increased interleukin-10 serum levels in patients with solid tumours

Claudio Fortis, Marco Foppoli, Luca Gianotti et al. · Cancer Letters · 1996 · 155 citations

Life Sciences, Immunology, Oncology +14

High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, Maria Giuseppina Cabras et al. · Journal of Clinical Oncology · 2015 · 121 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Risk‐tailored <scp>CNS</scp> prophylaxis in a mono‐institutional series of 200 patients with diffuse large B‐cell lymphoma treated in the rituximab era

Andrés J.M. Ferreri, Marta Bruno‐Ventre, Giovanni Donadoni et al. · British Journal of Haematology · 2014 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

Andrés J.M. Ferreri, Stefania Dell’Oro, Marco Foppoli et al. · Neurology · 2006 · 94 citations

Medicine, Oncology, Radiation Oncology +13